NCT00481845 2017-02-07Phase 2 Anastrozole and Vandetanib (ZD6474) in Neoadjuvant Treatment of Postmenopausal Hormone Receptor-Positive Breast CancerStanford UniversityPhase 2 Terminated1 enrolled 8 charts
NCT00494481 2016-09-30E3 Breast Cancer Taxotere CombinationSanofiPhase 2 Completed64 enrolled 7 charts